Moolec Science (MLEC) Non-Current Deferred Tax Liability (2023 - 2026)
Moolec Science's (MLEC) quarterly Non-Current Deferred Tax Liability came in at $14.3 million in Q1 2026, little changed quarter-over-quarter from $14.3 million in Q4 2025.
Moolec Science (MLEC) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
Moolec Science has disclosed Non-Current Deferred Tax Liability across 4 years of filings, most recently posting $14.3 million for Q1 2026.
- Non-Current Deferred Tax Liability for Q1 2026 came in at $14.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $14.3 million (changed N/A YoY), and the FY2025 annual result was $14.4 million, down 58.18% from the prior year.
- Non-Current Deferred Tax Liability came in at $14.3 million for Q1 2026 at Moolec Science, roughly flat from $14.3 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $34.5 million in Q2 2024 to a low of $40491.0 in Q3 2024.
- The 4-year median for Non-Current Deferred Tax Liability is $1.1 million (2023), against an average of $7.5 million.
- Across the five-year window, Non-Current Deferred Tax Liability slumped 95.2% in 2024 and soared 4424.96% in 2025, its largest moves.
- Moolec Science's Non-Current Deferred Tax Liability stood at $323391.0 in 2023, then declined by 2.27% to $316039.0 in 2024, then jumped by 4424.96% to $14.3 million in 2025, then slipped by 0.0% to $14.3 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $14.3 million (Q1 2026), $14.3 million (Q4 2025), and $14.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.30 Mn |
| Mar 31, 2026 | 14.30 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Jun 30, 2025 | 14.43 Mn |
| Jun 30, 2025 | 14.43 Mn |
| Dec 31, 2024 | 316,039.00 |
| Dec 31, 2024 | 316,039.00 |
| Sep 30, 2024 | 40,491.00 |
| Sep 30, 2024 | 40,491.00 |
| Jun 30, 2024 | 34.50 Mn |
| Jun 30, 2024 | 34.50 Mn |
| Mar 31, 2024 | 588,965.00 |
| Mar 31, 2024 | 588,965.00 |
| Dec 31, 2023 | 323,391.00 |
| Dec 31, 2023 | 323,391.00 |
| Sep 30, 2023 | 843,032.00 |
| Sep 30, 2023 | 843,032.00 |
| Jun 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.07 Mn |